Unlike CAR-T cells, NK cells don’t need genetic modification to recognize a specific threat — they act broadly without ...

For the new therapy, these cells are derived from stem cells that originated from healthy adult donor tissue - called induced pluripotent stem cells (iPSCs) - to make therapeutic CAR-NK cells.

Researchers identify target to enhance NK cell function for liver cancer therapy in Korea New insights into immune cell dynamics could lead to innovative therapies for cancer in Korea.

NK cell therapy is fast developing into a busy field, so it's something of a coup for Shoreline to forge an alliance with an established player like Gilead/Kite.

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage ...

The persistence of NK-92/5.28.z cells at tumor sites demonstrates efficient antitumor response, which could help overcome current obstacles in the treatment of solid tumors. Discussion: These findings ...

For the new therapy, these cells are derived from stem cells that originated from healthy adult donor tissue—called induced pluripotent stem cells (iPSCs)—to make therapeutic CAR-NK cells.

This state helps the rapid shift in expression above the baseline during the target recognition process. Treatment with UNC1999 could induce NK cell degranulation. In addition, the expression of IFN-γ ...

Copyright held by the owner/author(s).